Connect With UsI'm a Patient
Narcolepsy Link logo
Narcolepsy Link logo
  • About Narcolepsy
    • Pathophysiology
  • Screening & Diagnosis
    • Identifying Narcolepsy
    • Screeners
    • Diagnostic Criteria
    • Diagnostic Process
    • Diagnostic Challenges
  • Comorbidity Risk
    • Cardiovascular Comorbidities
    • Modifiable Risks for CV Disease
    • High Sodium Intake and CV Disease
    • Excess Sodium Intake Impact on Certain Body Systems
    • Psychiatric and Sleep Comorbidities
  • Disease Management
    • Management Considerations
  • Pediatric Patients
    • Burden of Illness
    • Symptoms
    • Clinical Interview
    • Differential Diagnosis
    • Screening
    • Patient and Caregiver Perspectives
  • Stay Connected
    • Connect With Us
    • Sleep Organizations
    • About NarcolepsyLink
  • Resources
    • Expert Clinical Insights
    • Clinical Resources
    • Narcolepsy FAQs
    • Glossary of Terms

Epworth Sleepiness Scale

The Epworth Sleepiness Scale (ESS) measures the general level of daytime sleepiness. It is a subjective scale that asks the respondent to rate his or her propensity to doze or fall asleep during 8 common daily activities to determine the level of daytime sleepiness.1

AASM provides quality measures for managing patients with narcolepsy2
Discover these approaches

AASM, American Academy of Sleep Medicine.

Features of the ESS

Download screening tools
Purpose:

Designed to measure general level of daytime sleepiness1

Population:

All patients for whom the clinician may want to evaluate the level of daytime sleepiness1

Assessments:

Assesses the responder's propensity to doze or fall asleep during 8 common daily activities, such as: sitting and reading; sitting inactive in a public place; sitting and talking to someone; sitting quietly after a lunch without alcohol; or in a car, while stopped for a few minutes in traffic1,3

Method:

Patient self-report1

Time required:

Consists of 8 questions and takes only a few minutes to complete1

Scoring:

Propensity for dozing is rated for each situation on a 4-point scale, from 0, indicating “would never doze,” to 3, indicating a “high chance of dozing.” Adding the scores for each of the 8 questions yields a total score ranging from 0-24.1,3

Interpretation:

An ESS score >10 suggests excessive daytime sleepiness (EDS).2 An ESS score ≥16 suggests a high level of EDS.1 Scores within this range are generally associated with significant sleep disorders, including narcolepsy.1 A high ESS score is suggestive of EDS only and is not diagnostic for a specific sleep disorder. Patients with EDS (ie, ESS >10) may need to be evaluated for a potential sleep disorder, including narcolepsy.1,3

A narcolepsy diagnosis should be established by a sleep specialist using a clinical interview and a nighttime polysomnogram (PSG) followed by a multiple sleep latency test (MSLT) performed under standardized conditions.4

The Epworth Sleepiness Scale is from: Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540-545. This copyrighted material is used with permission granted by the Associated Professional Sleep Societies - October 2012. Unauthorized copying, printing, or distribution of this material is strictly prohibited.
  1. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540-545.
  2. Krahn LE, Hershner S, Loeding LD, et al. Quality measures for the care of patients with narcolepsy. J Clin Sleep Med. 2015;11(3):335-355.
  3. Johns M, Hocking B. Excessive daytime sleepiness: daytime sleepiness and sleep habits of Australian Workers. Sleep. 1997;20(10):844-849.
  4. American Academy of Sleep Medicine. Central disorders of hypersomnolence. In: The International Classification of Sleep Disorders – Third Edition (ICSD-3) Online Version. Darien, IL: American Academy of Sleep Medicine; 2014.
Jazz Pharmaceuticals Logo
NarcolepsyLink® is sponsored by Jazz Pharmaceuticals
©2025 Jazz Pharmaceuticals, Inc.
US-SLE-2100121 REV1224
Terms of UseConnect With UsPrivacy StatementSite MapAbout NarcolepsyLink
Jazz Pharmaceuticals Logo